HCQ4Surf-E-Rare
 |
The HCQ4Surfdefect project is a randomized, placebo-controlled, phase 2 clinical trial for patients with genetically determined interstitla lung disease. The project is funded by the German center for lung research (DZL) and E-Rare until 2021. |
